Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-02

Clinical Trial Update: Effect of Entacapone on Bodyweight Loss in Obese Population [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study assessing entacapone for bodyweight loss in obesity; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entacapone (Entacapone)

Snippet

Sponsor: Kaichun Wu | Conditions: Obesity | Phase 1, Phase 2 | Status: UNKNOWN